Literature DB >> 17570117

The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa.

Viviane Balloy1, Amrisha Verma, Sudha Kuravi, Mustapha Si-Tahar, Michel Chignard, Reuben Ramphal.   

Abstract

The flagellum of Pseudomonas aeruginosa has been implicated in acute pneumonia, and its flagellin is known to cause lung inflammation. However, its proinflammatory role, versus its motility function, as a cause of death by a whole bacterium has not been demonstrated. This issue was examined in a lung model of acute infection using different flagellar mutants. We found that the absence of motility does not significantly alter the LD(50), whereas the production of excess amounts of flagellin lowers it and results in early death. Next, we found that the absence of the Toll-like receptor 5 (TLR5) ligand, flagellin, results in slower clearance of this organism from the lungs and a delay in the time to death. These findings demonstrate the dual role of flagellin in host defense and in disease and suggest that the death in this model may be biphasic with flagellin playing a role early in the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570117     DOI: 10.1086/518610

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression.

Authors:  Eyal Amiel; Rustin R Lovewell; George A O'Toole; Deborah A Hogan; Brent Berwin
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

2.  Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing.

Authors:  Delphyne Descamps; Mathieu Le Gars; Viviane Balloy; Diane Barbier; Sophia Maschalidi; Mira Tohme; Michel Chignard; Reuben Ramphal; Bénédicte Manoury; Jean-Michel Sallenave
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Authors:  Natalia Muñoz; Laurye Van Maele; Juan M Marqués; Analía Rial; Jean-Claude Sirard; José A Chabalgoity
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 4.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

5.  Escherichia coli flagellin stimulates pro-inflammatory immune response.

Authors:  Ayaid Khadem Zgair
Journal:  World J Microbiol Biotechnol       Date:  2012-02-12       Impact factor: 3.312

6.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

7.  Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

Authors:  Reuben Ramphal; Viviane Balloy; Jeevan Jyot; Amrisha Verma; Mustapha Si-Tahar; Michel Chignard
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia.

Authors:  Taylor S Cohen; Alice S Prince
Journal:  J Clin Invest       Date:  2013-03-08       Impact factor: 14.808

9.  Swarming motility, secretion of type 3 effectors and biofilm formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolates.

Authors:  Thomas S Murray; Michel Ledizet; Barbara I Kazmierczak
Journal:  J Med Microbiol       Date:  2010-01-21       Impact factor: 2.472

10.  Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells.

Authors:  Eloïse Raoust; Viviane Balloy; Ignacio Garcia-Verdugo; Lhousseine Touqui; Reuben Ramphal; Michel Chignard
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.